HK1117407A1 - Compositions and methods for enhancing contrast in imaging - Google Patents

Compositions and methods for enhancing contrast in imaging

Info

Publication number
HK1117407A1
HK1117407A1 HK08108437.6A HK08108437A HK1117407A1 HK 1117407 A1 HK1117407 A1 HK 1117407A1 HK 08108437 A HK08108437 A HK 08108437A HK 1117407 A1 HK1117407 A1 HK 1117407A1
Authority
HK
Hong Kong
Prior art keywords
imaging
compositions
methods
enhancing contrast
enhancing
Prior art date
Application number
HK08108437.6A
Other languages
English (en)
Chinese (zh)
Inventor
Ananth Annapragada
Ravi V Bellamkonda
Eric Hoffman
Chandra Vijayalakshmi
Original Assignee
Marval Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marval Biosciences Inc filed Critical Marval Biosciences Inc
Publication of HK1117407A1 publication Critical patent/HK1117407A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK08108437.6A 2004-04-21 2008-07-30 Compositions and methods for enhancing contrast in imaging HK1117407A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/830,190 US7713517B2 (en) 2004-04-21 2004-04-21 Compositions and methods for enhancing contrast in imaging
PCT/US2005/000876 WO2005107820A1 (en) 2004-04-21 2005-01-12 Compositions and methods for enhancing contrast in imaging

Publications (1)

Publication Number Publication Date
HK1117407A1 true HK1117407A1 (en) 2009-01-16

Family

ID=35136670

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08108437.6A HK1117407A1 (en) 2004-04-21 2008-07-30 Compositions and methods for enhancing contrast in imaging

Country Status (8)

Country Link
US (4) US7713517B2 (xx)
EP (2) EP1742669B1 (xx)
JP (2) JP5210630B2 (xx)
CN (1) CN101123996B (xx)
AU (1) AU2005239980B2 (xx)
CA (1) CA2563692C (xx)
HK (1) HK1117407A1 (xx)
WO (1) WO2005107820A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357351B2 (en) * 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
JP5072275B2 (ja) * 2006-07-03 2012-11-14 テルモ株式会社 閉鎖小胞の分離方法、製剤の製造方法および評価方法
CA2600220C (en) * 2006-09-07 2014-12-09 Canadian Blood Services Surface cross-linked lipidic particles, methods of production and uses therefor
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080175887A1 (en) 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
EP2219587A4 (en) * 2007-11-14 2012-11-21 Univ California STEROL-MODIFIED AMPHIPHILE LIPIDES
CA2708028A1 (en) * 2007-12-05 2009-06-11 Marval Biosciences, Inc. Nano-scale contrast agents and methods of use
US8956591B2 (en) 2008-05-15 2015-02-17 Osaka Prefectural Hospital Organization Method for detecting cancer using ICG fluorescence method
WO2009152445A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
WO2010024898A2 (en) 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
CA2755998A1 (en) * 2009-03-19 2010-09-23 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
US20130116554A1 (en) * 2010-07-12 2013-05-09 Ge Healthcare As X-ray imaging at low contrast agent concentrations and/or low dose radiation
US8658614B2 (en) 2010-08-13 2014-02-25 The University of Texas Health Science Center Aptamer-containing compositions and methods for targeting E-selectin
US9801957B2 (en) * 2011-04-06 2017-10-31 Ananth Annapragada Lipid-based nanoparticles
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
WO2013104690A1 (en) 2012-01-11 2013-07-18 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
JP6130401B2 (ja) 2012-01-20 2017-05-17 アンナプラガダ，アナンス 医学画像を客観的に特徴付けるための方法および組成物
WO2014047116A1 (en) * 2012-09-18 2014-03-27 Comfort Care For Animals Llc Encapsulating liposomes
EP3047271B1 (en) * 2013-09-20 2022-05-11 California Institute Of Technology Methods for phenotyping of intact whole tissues
ES2743704T3 (es) 2014-10-08 2020-02-20 Texas Childrens Hospital Obtención de imágenes de IRM de la placa amiloide usando liposomas
CN109513017B (zh) * 2018-12-27 2021-09-21 中国科学院高能物理研究所 一种脂质纳米囊及其制备方法和应用
CN115957351B (zh) * 2022-11-15 2023-06-27 中国人民解放军海军第九七一医院 一种碘海醇注射液及其制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5204085A (en) * 1985-01-08 1993-04-20 Mallinckrodt Medical, Inc. Method for enhancing the safety of metal-ligand chelates as X-ray contrast agents
CH672733A5 (xx) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
CA1335348C (en) * 1988-03-04 1995-04-25 Yasuaki Ogawa Liposome composition
US4994213A (en) 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
DE68916956T2 (de) * 1988-05-20 1994-11-24 Liposome Co Inc Aktives mittel: lipid-komplex mit hohem verhältnis.
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5230882A (en) * 1989-12-22 1993-07-27 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
IN172208B (xx) * 1990-04-02 1993-05-01 Sint Sa
GB9314499D0 (en) * 1993-07-12 1993-08-25 Nycomed Imaging As Method
US6217849B1 (en) * 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
DE4341472A1 (de) * 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
JP3759765B2 (ja) * 1994-03-28 2006-03-29 第一製薬株式会社 リポソーム
DE69527194T2 (de) * 1994-03-28 2003-02-06 Daiichi Pharmaceutical Co., Ltd. Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel
US5811581A (en) * 1994-08-04 1998-09-22 Dibra S.P.A. Process for the purification of opacifying contrast agents
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
NZ334365A (en) * 1996-08-02 1999-10-28 Nycomed Imaging As Use of a contrast agent comprising microbubbles of biocompatible gas stabilised by opsonisable amphiphilic material for ultrasound imaging of the liver
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
AU7104598A (en) * 1997-04-09 1998-10-30 Philipp Lang New technique to monitor drug delivery noninvasively (in vivo)
CA2286138A1 (en) * 1997-04-11 1998-10-22 Marc A. Longino Blood-pool carrier for lipophilic imaging agents
US6818213B1 (en) * 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
JP2002527466A (ja) 1998-09-16 2002-08-27 アルザ・コーポレーション リポソーム−閉込めトポイソメラーゼ阻害剤
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
US6425864B1 (en) 1999-04-15 2002-07-30 General Electric Company Method and apparatus for optimal imaging of the peripheral vasculature
KR20030038814A (ko) * 2000-10-11 2003-05-16 타게솜, 인크. 표적 치료제
PL369545A1 (en) 2001-09-28 2005-05-02 Esperion Therapeutics, Inc. Methods and apparatus for extrusion of vesicles at high pressure
US7138136B2 (en) * 2002-03-05 2006-11-21 Cleveland State University Agglomerated particles for aerosol drug delivery
US20060235296A1 (en) 2003-02-13 2006-10-19 Bracco Imaging S.P.A. Contrast enhanced x-ray phase imaging
JP2005170923A (ja) 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
US8357351B2 (en) * 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
EP1848464B1 (en) 2005-02-11 2014-04-23 University Health Network Compositions and methods for multimodal imaging
US20080213350A1 (en) 2007-02-20 2008-09-04 Texas Tech University System Encapsulation of nucleic acids in liposomes
CA2708028A1 (en) * 2007-12-05 2009-06-11 Marval Biosciences, Inc. Nano-scale contrast agents and methods of use
WO2009152445A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
CA2755998A1 (en) * 2009-03-19 2010-09-23 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging

Also Published As

Publication number Publication date
JP2013049702A (ja) 2013-03-14
CA2563692A1 (en) 2005-11-17
AU2005239980B2 (en) 2010-02-25
EP1742669B1 (en) 2015-07-08
JP5210630B2 (ja) 2013-06-12
CA2563692C (en) 2013-05-14
JP2007533737A (ja) 2007-11-22
WO2005107820A1 (en) 2005-11-17
USRE45195E1 (en) 2014-10-14
US20080131369A1 (en) 2008-06-05
EP2578237A1 (en) 2013-04-10
US20070212303A1 (en) 2007-09-13
US20050238584A1 (en) 2005-10-27
CN101123996B (zh) 2014-07-16
EP1742669A4 (en) 2010-06-23
US7785568B2 (en) 2010-08-31
AU2005239980A1 (en) 2005-11-17
US7713517B2 (en) 2010-05-11
CN101123996A (zh) 2008-02-13
EP1742669A1 (en) 2007-01-17

Similar Documents

Publication Publication Date Title
HK1117407A1 (en) Compositions and methods for enhancing contrast in imaging
EP1718282A4 (en) PROCESS AND COMPOSITIONS FOR IMAGE PRESENTATION
GB2412919B (en) Polishing composition and polishing method
GB0505446D0 (en) Polishing composition and polishing method
SG115831A1 (en) Polishing composition and polishing method
HK1163995A1 (en) Imaging arrangement and method therefor
EP1895838A4 (en) COMPOSITIONS AND METHODS
EP1841558A4 (en) METHOD AND COMPOSITION FOR ELECTROCHEMICAL MECHANICAL POLISHING
GB0522287D0 (en) Method and compositions
EP1893121A4 (en) IMPROVEMENTS IN COMPONENTS FOR PERMANENT REMOVABLE AND ADJUSTABLE BITES AND BRIDGES
GB0525314D0 (en) Method and composition
GB0619096D0 (en) Polishing composition and polishing method
EP1827095A4 (en) COMPOSITIONS AND METHODS FOR TRANSPIRATION PROTECTION IN PLANTS
SG115786A1 (en) Polishing composition and polishing method
EP2018163A4 (en) ILLUSTRATIVE APPARATUS AND METHOD
EP1773386A4 (en) VACCINE COMPOSITIONS AND CORRESPONDING METHODS
GB0427145D0 (en) Compositions for use in surgery
SG131098A1 (en) Polishing composition and polishing method
IL184062A0 (en) Visco-supplement composition and methods
EP1747228A4 (en) NEW COMPOSITIONS AND METHODS IN THE FIELD OF CANCER
ZA200605722B (en) Composition and method
GB0524927D0 (en) Compositions and method
GB0417359D0 (en) Improvements in compositions
ZA200802969B (en) Composition and method
GB0522655D0 (en) Composition and method

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190109